(Q58404248)
Statements
A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis (English)
C Leonardi
B Conetta
R R Stoltz
P F Pierce
Ravuconazole onychomycosis group
1 reference
1 reference
1 reference